3396 279

Cited 0 times in

치매의 약물치료

Other Titles
 Pharmacotherapy for dementia 
 김형섭  ;  김용욱 
 Geriatric Rehabilitation, Vol.3(2) : 42-50, 2013 
Journal Title
 Geriatric Rehabilitation 
Issue Date
Pharmacotherapy for dementia has progressed from the use of psychiatric medications for behavior and psychiatric symptoms n to the use of rational treatments aimed at neurotransmitter replacement. The development of pharmacotherapy of dementia has mainly focused on the medications for Alzheimer’s disease (AD) because AD is most common among the subtypes of dementia and vascular dementia, the second most common type of dementia, could be preventive. Until now, the acetylcholinesterase inhibitors (AChEIs) and Memantine, an N-methyl-d-aspartic acid receptor antagonist were approved to AD. Acetyl cholinesterase inhibitors; donepezil, rivastigmine and galantamine have shown consistent efficacy across the spectrum of very mild to severe AD. Memantine has a better tolerability profile than the AChEIs and seems to have particular advantages on the non-cognitive symptoms related to agitation and language. However these medications have been at least partially successful in terms of symptomatic treatments and disease-modifying treatments. Researches on the underlying etiology and pathophysiology of AD are likely to facilitate identification of additional targets for newer drug development. However, various behavioral and psychological symptoms of dementia (BPSD) could be a heavier burden than the decline of cognitive function to the family and care givers. So it is very important for quality of life of family members and social costs to manage BPSD properly. The management of BPSD requires both pharmacological and non-pharmacological treatment. Pharmacological intervention should be considered for the patients with moderate to severe BPSD.
Files in This Item:
T201304330.pdf Download
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Rehabilitation Medicine (재활의학교실) > 1. Journal Papers
Yonsei Authors
김용욱(Kim, Yong Wook) ORCID logo https://orcid.org/0000-0002-5234-2454
RIS (EndNote)
XLS (Excel)
사서에게 알리기


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.